Skip to main content

Table 2 Multiple regression analysis of mean weekly warfarin dose (mg) related to genotypes, treatment group and age. Coefficients and significance levels are listed for each predictor. R2 values indicate the cumulative contribution of each predictor as they are entered into the model. P-value for the model was <0.0001.

From: Warfarin dose and INR related to genotypes of CYP2C9 and VKORC1 in patients with myocardial infarction

Predictor

Warfarin dose (mg)

Significance

Adjusted R2(cumulative)

Constant

72.297

P < 0.001

 

VKORC1 1173 T/T

-18.946

P < 0.001

0.101

VKORC1 1173 C/T

-11.930

P < 0.001

0.245

Treatment group

-8.540

P < 0.001

0.358

CYP2C9 *1/*2,*3

-7.275

P = 0.001

0.398

CYP2C9 *2/*2,*3

-15.459

P = 0.001

0.430

Age

-0.321

P = 0.004

0.472

  1. Dose [mg/week] = 72.297 - 18.946 · (T/T) -11.930· (C/T) - 8.540 · (group) -7.275 · (*1/*2,*3) - 15.459 · (*2/*2,*3) - 0.321· (age)